Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FBPPJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,202
Award facts
- Contract value 100% obligated
- $16,202.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $16,202 to DMS Pharmaceutical Group Inc. for the supply of 52 mg Mirena systems on January 23, 2026, with an ultimate completion date of February 13, 2026. This firm fixed-price delivery order was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain and specializes in distributing branded and generic prescription medications, biologics, vaccines, and medical consumables to Department of Defense facilities.
This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion DLA acquisition strategy designed to provide recurring medical supply support to military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under this program (contract SPE2DR) valued at $499,999,999 with an ultimate completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. The company's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, including contraceptive devices such as Mirena systems, oncology treatments, immunosuppressants, and emergency medications.
Quick answers
Who was awarded contract SPE2DR26FBPPJ?
SPE2DR26FBPPJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FBPPJ worth?
The government has obligated $16,202 on SPE2DR26FBPPJ.
Is contract SPE2DR26FBPPJ an order under another contract?
Yes. SPE2DR26FBPPJ is a delivery order under SPE2DR25D9309, an indefinite delivery contract.
Was contract SPE2DR26FBPPJ competed?
The extent of competition for SPE2DR26FBPPJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award